Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort.

PLoS neglected tropical diseases·2026
Same author

Visceral leishmaniasis elimination in South Asia: lessons learnt can inform disease elimination in East Africa.

BMJ global health·2026
Same author

Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape.

Frontiers in immunology·2026
Same author

Etiologies of community-acquired febrile illness identified by TaqMan Array Card qPCR on blood samples: a systematic review and meta-analysis.

Journal of clinical microbiology·2026
Same author

Entomological survey of sand fly vectors and molecular screening for Leishmania parasite in refugee camps in Ethiopia.

Scientific reports·2026
Same author

From dogma to data: charting a path forward for clinico-immunological research in Ethiopian cutaneous leishmaniasis.

Infectious diseases of poverty·2026

Related Experiment Video

Updated: May 22, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Visceral leishmaniasis.

Johan van Griensven1, Ermias Diro

  • 1Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, Antwerp, Belgium. jvangriensven@itg.be

Infectious Disease Clinics of North America
|May 29, 2012
PubMed
Summary
This summary is machine-generated.

Visceral leishmaniasis (VL), a neglected parasitic disease, presents with fever and organ enlargement. Diagnosis uses serologic/molecular tests, with treatment options including amphotericin B and newer drugs, especially considering HIV coinfection challenges.

More Related Videos

Investigating the Phagocytosis of Leishmania using Confocal Microscopy
08:41

Investigating the Phagocytosis of Leishmania using Confocal Microscopy

Published on: July 29, 2021

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

Related Experiment Videos

Last Updated: May 22, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Investigating the Phagocytosis of Leishmania using Confocal Microscopy
08:41

Investigating the Phagocytosis of Leishmania using Confocal Microscopy

Published on: July 29, 2021

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Tropical Medicine

Background:

  • Visceral leishmaniasis (VL) is a neglected vector-borne parasitic disease affecting macrophages.
  • Classical symptoms include chronic fever, hepatosplenomegaly, and pancytopenia.
  • Human immunodeficiency virus (HIV) coinfection presents significant diagnostic and therapeutic hurdles.

Purpose of the Study:

  • To provide an updated clinical review of visceral leishmaniasis.
  • To focus on clinical presentation, diagnosis, and management strategies.
  • To address the specific challenges posed by HIV coinfection in VL patients.

Main Methods:

  • Literature review of clinical studies on visceral leishmaniasis.
  • Analysis of diagnostic methods including serologic and molecular testing.
  • Evaluation of current and emerging therapeutic options for VL.

Main Results:

  • VL is characterized by specific clinical manifestations and is diagnosable via established tests.
  • Treatment has evolved from antimonials to include amphotericin B, paromomycin, and miltefosine.
  • HIV coinfection complicates VL management, requiring tailored approaches.

Conclusions:

  • This review synthesizes current knowledge on VL clinical aspects.
  • Effective management relies on accurate diagnosis and appropriate therapeutic choices.
  • Addressing HIV coinfection is crucial for improving VL patient outcomes.